Seppic acquires EPI France, strengthening its position in the nutricosmetic market
The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
Photo © iStockphoto.com/skynesher
Seppic (La Garenne Colombes, France) has acquired EPI France, strengthening its position in the nutricosmetic market. EPI France’s flagship ingredient, Ceramosides, clinically validated to support skin both orally and topically, has been distributed by Seppic for over ten years. The acquisition will strengthen Seppic’s expertise and know-how with the addition of EPI’s internal production tools, giving the firm control over the entire process of research, development, and industrialization, from the extraction of raw materials to the active ingredients.
“This acquisition opens up new growth opportunities for Seppic in the cosmetics and dietary supplements markets. We are very pleased to welcome EPI France teams to Seppic,” said Jean Baptiste Dellon, CEO of Seppic, in a press release. “Our long-standing relationship and the values of expertise, quality and customer care that we share with EPI France will allow us to quickly realize synergies for the development and marketing of new ingredients.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
